SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-042297
Filing Date
2024-04-05
Accepted
2024-04-05 16:33:13
Documents
1
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 9833
  Complete submission text file 0000950170-24-042297.txt   11287
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIVUS, INC. 351 EAST EVELYN AVENUE MOUNTAIN VIEW CA 94041
Business Address
Slebir John L (Reporting) CIK: 0001475990 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34207 | Film No.: 24826979